MetALD-ALD prediction index exposes an unresolved reassignment rule in MetALD
2026-09-18
Hiroyuki Suzuki, Shuhei Fukunaga, Tsubasa Tsutsumi, Keisuke Amano, Toru Nakamura, Takumi Kawaguchi
← Back to Journals
Hepatobiliary Surgery and Nutrition
- Publisher:
- —
- ISSN:
- 2304-3881
- Category:
- SURGERY
- Impact factor:
- 6.1
Feed status
47 parsed articles
Last update: 2026-10-23
Latest articles
Irreversible electroporation in hepatocellular carcinoma: from an anatomical niche to an immunologic platform
2026-09-18
Xiaokun Chen, Xiao Liu, Shunda Du, Kai-Wen Huang
Roy Calne, an iconic liver transplanter and compassionate artist
2026-09-18
Thomas M. van Gulik
Conversion therapy for biliary tract cancer: redefining survival through selection, response, and resectability
2026-09-17
Van Khanh Nguyen, Hoang Hai Duong, Thanh Tung Lai, Masaki Kaibori
Normal weight, hidden risk: adiposity is a better determinant of liver cancer than body mass index
2026-09-17
Eduardo H. Gilglioni, Ao Li, Latifa Bakiri, Esteban N. Gurzov
Are there true and false classifications in noninvasive liver disease assessment for metabolic dysfunction-associated steatotic liver disease?
2026-09-17
Tatsuki Ichikawa, Satoshi Miuma, Hisamitsu Miyaaki
Three-dimensional bioprinting in cholangiocarcinoma: from organoid-based drug screening to spatially engineered precision oncology
2026-09-16
Kai Zhang, Haifeng Xu
Preemptive governance of online public opinion risks in public hospitals
2026-09-15
Yuhong Chen, Ting Yu
An artificial intelligence-augmented electrocardiogram model can detect undiagnosed chronic liver disease, but can this be applied in primary care?
2026-09-10
Brad A. Keith, Samuel O. Schumann III, Andrew D. Schreiner
Metabolic dysfunction-associated steatotic liver disease (MASLD) versus metabolic dysfunction and alcohol-associated steatotic liver disease (Met-ALD), do the differences matter in clinical practice?
2026-09-09
Christopher D. Byrne
Balancing sensitivity and specificity in diagnostic and prognostic scoring systems for acute-on-chronic liver failure
2026-09-08
Kymentie Ferdinande, Alberto Zanetto, Marco Senzolo
Toward a combinatorial model of steatotic liver disease: integrating metabolism and alcohol
2026-09-07
Ludovico Abenavoli, Maria Luisa Gambardella
Conversion therapy in locally advanced biliary tract cancer: expanding the boundaries of resectability using ZSAB-TransGOLP regimen
2026-09-07
Jacopo Mascherini, Iswanto Sucandy
Advancing TCR-T cell therapy in hepatocellular carcinoma: lessons from the ADP-A2AFP trial
2026-09-04
Zuzana Macek Jilkova, Carole Fournier, Thomas Decaens
Immune-mediated adverse events as a window into antitumor immunity in hepatocellular carcinoma: lessons and future directions from the HIMALAYA trial
2026-09-04
Takehiro Okabayashi
Editorial for PREOPANC-2, a multicenter, open-label, phase 3 randomized trial comparing neoadjuvant FOLFIRINOX vs. neoadjuvant gemcitabine based chemoradiotherapy in resectable and borderline resectable pancreatic cancer
2026-09-03
Chunjie Li, Kian-Huat Lim
Cryoablation with sintilimab and lenvatinib for intrahepatic cholangiocarcinoma: Does the addition of locoregional therapy augment survival outcomes?
2026-09-03
Emily C. Smith, Nicole H. Ducich, Jonathan M. Hernandez
Vaccinating against the ‘undruggable’—a new paradigm for fibrolamellar carcinoma
2026-09-03
Meghana Singh, Anwaar Saeed
Neoadjuvant immuno-chemotherapy combined with antiangiogenic therapy for patients with resectable high-risk intrahepatic cholangiocarcinoma and excellent performance status: interim efficacy results from the ZSAB-neoGOLP trial
2026-09-03
Marco Gerling, Hannes Jansson
Toward more practical hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: clinical implications of fibrosis-based risk stratification
2026-08-13
Hae Lim Lee, Minjong Lee
The GOLP regimen: pushing the boundaries of conversion therapy in locally advanced biliary tract cancer
2026-08-03
Takeshi Okamoto
Overcoming immune exclusion in intrahepatic cholangiocarcinoma: mechanistic insights from the CASTLE01 trial
2026-07-27
Takahiro Yamasaki, Yutaka Suehiro, Issei Saeki, Maho Egusa, Norikazu Tanabe, Taro Takami
When a suspicious liver lesion is not cancer: primary hepatic myopericytoma in chronic hepatitis B
2026-07-24
Xiao Liu, Xiaokun Chen, Xiaoyan Chang, Shunda Du
Emergency remote robotic right hepatectomy for spontaneous rupture of hepatocellular carcinoma
2026-07-17
Fengwei Gao, Zhigui Li, Xin Zhao, Qingyun Xie, Zongtao Song, Bingran Zhang, Xiang Zhu, Zhenghao Su, Danzeng Laba, Taqing Suoba, Xiaoou Li, Wei Yuan, Jun Ma, Mengsong Wang, Tian Lan, Yaowen Jiang, Nian Li, Yunshi Cai, Jiayin Yang, Hong Wu
Microwave ablation-assisted laparoscopic partial splenectomy with multi-angle layered ablation
2026-07-17
Wenliang Tan, Jinxing Wei, Chuchu Tan, Yajin Chen, Changzhen Shang
Microbiome research in liver transplantation
2026-07-16
Ulrich Wirth, Josefine Schardey, Christian Schulz, Joachim Andrassy
The hidden culprit: mesenteric venous occlusion presenting as refractory upper gastrointestinal bleeding post‑Whipple
2026-07-08
Mucong Li, Yingfan Li, Fengdan Wang, Tao Guo, Menghua Dai, Gechong Ruan, Hong Yang
Two grafts, one implant: ex vivo assembly and en bloc piggyback implantation for dual-graft liver transplantation
2026-06-25
Xi Xu, Chen Jin, Yiliyaer Aierken, Jiulin Song, Tong Chen, Wei Gao, Youlong Wu, Feihong Weng, Shouping Wang, Jian Yang, Tao Lv, Gang Xu, Jiayin Yang
Mechanical hypertrophy versus biological optimization: rethinking the role of ALPPS in the era of systemic therapy
2026-06-25
Yu-Han Cui, Guo-Qing Zhang, Xin Liang, Zu-Chao Du, Jia-Hao Xu, Li-Hui Gu, Ming-Da Wang, Chao Li, Tian Yang
Photon-counting CT-guided precise subtotal resection of pancreatic head benign tumor with complete protection of pancreaticoduodenal arcades
2026-06-25
Jiashu Han, Mengwei Wu, Jingyi Liu, Liang Zhu, Weibin Wang, Chen Lin